.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Julphar
Chubb
Mallinckrodt
Medtronic
Colorcon
Harvard Business School
Argus Health
Cantor Fitzgerald
Baxter

Generated: July 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Antifungal composition with enhanced bioavailability
Abstract: A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: ##STR00001## at least one thickening agent, a non-ionic surfactant, and a pharmaceutically acceptable liquid carrier is disclosed.
Inventor(s): Sharpe; Stefan (Jersey City, NJ), Sequeira; Joel (Edison, NJ), Harris; David (New Providence, NJ), Mahashabde; Shashank (Kendall Park, NJ)
Assignee: Merck Sharp & Dohme Corp. (Rahway, NJ)
Application Number:13/161,097
Patent Claims: 1. A liquid suspension comprising: 40 mg/ml of a micronized compound represented by the chemical structural formula I: ##STR00008## wherein the micronized compound of formula I has a mean particle size of about 1800 nm; Polysorbate 80; an effective amount of a buffer system comprising sodium citrate and citric acid sufficient to maintain a pH in the range of about 4.0 to about 6.0; a combination of thickening agents comprising xanthan gum and liquid sugar; and a pharmaceutically acceptable liquid carrier comprising glycerin.

2. A liquid suspension comprising: 40 mg/ml of a micronized compound represented by the chemical structural formula I: ##STR00009## wherein the micronized compound of formula I has a mean particle size of about 1000 nm to about 1800 nm; Polysorbate 80; an effective amount of a buffer system comprising sodium citrate and citric acid sufficient to maintain a pH in the range of about 4.0 to about 6.0; a combination of thickening agents comprising xanthan gum and liquid sugar; and a pharmaceutically acceptable liquid carrier comprising glycerin.

3. A liquid suspension comprising: posaconazole (micronized), represented by the chemical structural formula I: ##STR00010## wherein the micronized compound of formula I has a mean particle size of about 1000 nm to about 1800 nm in an amount of about 40 mg/ml; Polysorbate 80, in an amount between about 5 mg/ml and about 50 mg/ml; sodium citrate, in an amount between about 0.4 and about 0.8 mg/ml; citric acid, in an amount between about 0.36 and about 0.6 mg/ml; simethicone, in an amount between about 2 mg/ml and about 4 mg/ml; xanthan gum, in an amount between about 1 mg/ml and about 5 mg/ml; sodium benzoate, in an amount between about 0.5 mg/ml and about 3 mg/ml; liquid glucose, in an amount between about 200 mg/ml and about 500 mg/ml; and glycerin, in an amount between about 50 mg/ml and about 150 mg/ml.

4. The liquid suspension of claim 1, wherein the suspension further comprises purified water.

5. The liquid suspension of claim 1, wherein the suspension further comprises: artificial cherry flavor, in an amount between about 2 mg/ml and about 10 mg/ml; and titanium dioxide, in an amount about 2 mg/ml and about 6 mg/ml.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Colorcon
Citi
Federal Trade Commission
QuintilesIMS
Boehringer Ingelheim
Accenture
Express Scripts
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot